Analyst Ranking
Bottom 4%
#4803 out of 5002 analysts
Average Return
-7.72%
Win Rate
37%28 out of 76
Risk vs Reward
Poor
Good

Brandon Folkes's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Connect Biopharma Holdings LtdCNTB
+134.12%$0.85$1.99
2025-06-11 -
2025-09-03
Buy
Elutia IncELUT
+130.77%$1.43$3.30
2023-08-14 -
2024-08-14
Strong Buy
Trevi Therapeutics IncTRVI
+122.74%$2.77$6.17
2024-06-12 -
2025-06-12
Strong Buy
Cormedix IncCRMD
+118.98%$6.27$13.73
2024-08-25 -
2025-08-25
Strong Buy
Eupraxia Pharmaceuticals IncEPRX
+86.21%$2.90$5.40
2024-11-13 -
2025-09-03
Strong Buy

Brandon Folkes Analyst Color

Get additional color on Brandon Folkes's coverage of popular stocks

Brandon Folkes's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Mannkind CorpMNKD
4Buy$11.00+99.64%Maintains
2 days ago
Valneva SeVALN
2Buy$18.00+105.25%Reiterates
10 days ago
Journey Medical CorpDERM
2Buy$13.00+87.05%Initiates Coverage On
10 days ago
Achieve Life Sciences IncACHV
2Buy$12.00+319.58%Initiates Coverage On
14 days ago
Eupraxia Pharmaceuticals IncEPRX
3Buy$12.00+122.22%Reiterates
15 days ago
Genfit SaGNFT
1Buy$9.00+127.85%Assumes
16 days ago
Polypid LtdPYPD
4Buy$13.00+280.12%Reiterates
22 days ago
Connect Biopharma Holdings LtdCNTB
2Buy$7.00+251.76%Reiterates
22 days ago
Xeris Biopharma Holdings IncXERS
1Buy$10.00+27.55%Assumes
23 days ago
Collegium Pharmaceutical IncCOLL
4Buy$44.00+11.14%Assumes
24 days ago
Ani Pharmaceuticals IncANIP
4Buy$93.00-2.02%Maintains
a month ago
Cormedix IncCRMD
3Buy$17.00+24.09%Maintains
a month ago
Sagimet Biosciences IncSGMT
1Buy$29.00+295.10%Assumes
a month ago
Indivior PLCINDV
1Buy$28.00+13.50%Initiates Coverage On
a month ago
Enanta Pharmaceuticals IncENTA
1Buy$20.00+126.76%Assumes
a month ago
Zevra Therapeutics IncZVRA
1Buy$26.00+191.48%Initiates Coverage On
2 months ago
Heron Therapeutics IncHRTX
2Buy$6.00+351.13%Initiates Coverage On
3 months ago
Milestone Pharmaceuticals IncMIST
2Buy$5.00+180.90%Assumes
3 months ago
Cardiol Therapeutics IncCRDL
1Buy$9.00+725.69%Initiates Coverage On
3 months ago
Trevi Therapeutics IncTRVI
2Buy$21.00+193.71%Initiates Coverage On
3 months ago
Rockwell Medical IncRMTI
1Strong Buy$5.00+189.02%Initiates Coverage On
10 months ago
Omeros CorpOMER
1Strong Buy$9.00+115.31%Initiates Coverage On
10 months ago
Adial Pharmaceuticals IncADIL
1Strong Buy$8.00+2,039.04%Initiates Coverage On
10 months ago
Emergent Biosolutions IncEBS
4Strong Buy$16.00+104.34%Reiterates
a year ago
Rani Therapeutics Holdings IncRANI
2Strong Buy$10.00N/AInitiates Coverage On
a year ago
Scilex Holding CoSCLX
1Strong Buy$455.00N/AInitiates Coverage On
a year ago
Sanara Medtech IncSMTI
4Strong Buy$59.00N/AReiterates
2 years ago
Jazz Pharmaceuticals PLCJAZZ
2Strong Buy$180.00N/AReiterates
2 years ago
Elutia IncELUT
3Strong Buy$8.00N/AReiterates
2 years ago
Amryt Pharma PLCAMYT
2Hold$14.75N/ADowngrades
3 years ago
Veru IncVERU
3Strong Buy$220.00N/AMaintains
3 years ago
Sorrento Therapeutics IncSRNEQ
1Strong Buy$5.00N/AInitiates Coverage On
3 years ago
Obseva SaOBSVF
1Strong Buy$6.00N/AInitiates Coverage On
3 years ago
Alkermes PLCALKS
1Strong Buy$32.00N/AUpgrades
4 years ago
IMV IncIMVIQ
1Strong Buy$40.00N/AInitiates Coverage On
4 years ago
Redhill Biopharma LtdRDHL
1Strong Buy$22,000.00N/AInitiates Coverage On
4 years ago
Trevena IncTRVN
1Strong Buy$3,125.00N/AInitiates Coverage On
5 years ago
Optinose IncOPTN
3Strong Buy$315.00N/AReiterates
5 years ago
Eagle Pharmaceuticals IncEGRX
2Hold$46.00N/AMaintains
6 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$30.00N/AReiterates
6 years ago
Opiant Pharmaceuticals IncOPNT
1Strong Buy$42.00N/AMaintains
7 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Strong Buy$50.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.